Announced Fri, 4 Sept · 16:30 IST
API Holdings absorbs Docon; 51.02% stake in Thyrocare vests in API
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.0%1-day move
₹576.40
prior close
₹573.75
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.1-0.1+0.1-1.0-1.2-3.2-4.1-4.9-2.9————
Up moveDown movePending
AI summary
API Holdings Ltd merged with its group company Docon Technologies, effective Sept 3, 2026, after NCLT approval on Aug 31. Docon's 51.02% stake (8,12,00,000 shares) in Thyrocare automatically vested in API Holdings by operation of law. No change in ultimate promoter holding of Thyrocare. Disclosed under Reg 10(6), exempted from open offer under Reg 10(1)(d)(iii).
Likely market impact
Internal group restructuring; Thyrocare's promoter control and shareholding pattern remain unchanged. No impact on minority shareholders.